Pure Tech Elects Robert Lyne as Chief Executive Officer
PureTech Health plc, a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today announces that the Board of Directors has appointed Robert Lyne as Chief Executive Officer (CEO) and as a member of the Board of Directors, effective immediately. Robert Lyne commented: “I’m honored to lead PureTech as CEO […]
VION Biosciences Acquires Echelon Biosciences
VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announced the recent acquisition of Salt Lake City-based Echelon Biosciences, a trusted supplier of critical materials, notably lipid-based excipients, to its growing portfolio. This acquisition serves as the second investment under VION Biosciences LLC […]
PureTech Announces the Appointment of Michele Holcomb, PhD, to the Board of Directors
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, recently announced that Michele Holcomb, PhD, will join its board of directors as an independent non-executive director. Dr. Holcomb’s appointment will take effect as of September 23, 2024. She brings more […]
